- Home
- AVPT vs ICUI Comparison
AVPT vs ICUI Comparison
Compare AVPT & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AVPT | ICUI |
|---|---|---|
| Founded | 2001 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 3.2B |
| IPO Year | N/A | 1992 |
Fundamental Metrics
Financial Performance| Metric | AVPT | ICUI |
|---|---|---|
| Price | $12.84 | $146.24 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 6 |
| Target Price | $18.38 | ★ $183.60 |
| AVG Volume (30 Days) | ★ 1.7M | 306.9K |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | $393,993,000.00 | ★ $2,320,363,000.00 |
| Revenue This Year | $26.20 | N/A |
| Revenue Next Year | $18.17 | N/A |
| P/E Ratio | $1,622.55 | ★ N/A |
| Revenue Growth | ★ 24.71 | N/A |
| 52 Week Low | $11.49 | $107.00 |
| 52 Week High | $20.25 | $175.51 |
Technical Indicators
Market Signals| Indicator | AVPT | ICUI |
|---|---|---|
| Relative Strength Index (RSI) | 41.53 | 64.56 |
| Support Level | $12.61 | $131.99 |
| Resistance Level | $13.03 | $150.38 |
| Average True Range (ATR) | 0.33 | 5.17 |
| MACD | 0.07 | 0.60 |
| Stochastic Oscillator | 41.41 | 67.78 |
Price Performance
Historical ComparisonAbout AVPT AvePoint Inc.
AvePoint Inc provides customizable solutions to optimize SaaS operations, enable secure collaboration, and accelerate digital transformation across technologies and industries. Its Confidence Platform delivers a comprehensive set of cloud-based solutions enabling IT operations, development operations, and cybersecurity professionals to monitor and secure the digital workplace using SaaS tools.
About ICUI ICU Medical Inc.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.